glp-1 for diabetic GLP-1-based therapies type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Benefits of Semaglutide GLP-1 |

The high cost of GLP-1 products is one of the most significant barriers to equitable access

Conflict of interest BG has served as a consultant for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Merck (MSD) and Novartis as manufacturers of DPP-4 inhibitors and has received honoraria from these companies for lectures

This synergy is often explored in protocols for musculoskeletal and tissue regeneration research

Generic Pepto-Bismol alternatives contain the same active ingredient, Bismuth Subsalicylate 262 mg, at the same dosage strength

In 2019, the FDA approved increasing the available doses of Ozempic to 2 mg

Bartels GL, Remme WJ, Holwerda KJ, Kruijssen DA